Evotec AG of Hamburg, Germany, has announced that it is collaborating
with Active Biotech AB to identify small-molecule modulators of a priority biological
target involved in immune disorders and cancer. The former, a drug discovery company,
will use its technologies in assay development and high-throughput and surface plasmon
resonance screening to identify and validate novel hits. It will screen its Lead
Discovery Library, a small-molecule collection, to maximize the probability of finding
medicinal chemistry starting points. Active Biotech of Lund, Sweden, develops pharmaceuticals
for diseases of the immune system.
- See acousto-optic modulator; electro-optic modulator.
MORE FROM PHOTONICS MEDIA